quinoxalines has been researched along with pirenzepine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, RO; Conde-Guerri, B; Matute, C; Miledi, R | 1 |
| Jiang, ZG; North, RA; Sugita, S; Uchimura, N | 1 |
| Changeux, JP; Vidal, C | 1 |
| Kauer, JA; Williams, JH | 1 |
| De Iuri, L; Imbrogno, S; Mazza, R; Tota, B | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Broadley, KJ; Gudka, N; Hamrouni, AM | 1 |
| Bellucci, C; Bolognesi, ML; Giorgi, G; Marucci, G; Matera, R; Melchiorre, C; Minarini, A; Rosini, M; Tumiatti, V | 1 |
8 other study(ies) available for quinoxalines and pirenzepine
| Article | Year |
|---|---|
mRNA coding for neurotransmitter receptors in a human astrocytoma.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Aged; Animals; Astrocytoma; Brain Neoplasms; Calcium Channels; Cell Line; Culture Techniques; Female; Glutamates; Humans; Kainic Acid; Kynurenic Acid; Male; Membrane Potentials; Oocytes; Pirenzepine; Quinoxalines; Quisqualic Acid; Receptors, Glutamate; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; RNA, Messenger; Xenopus | 1992 |
Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amygdala; Animals; Brain; Corpus Striatum; Diamines; gamma-Aminobutyric Acid; Glutamates; In Vitro Techniques; Kinetics; Muscarine; Neurons; Nucleus Accumbens; Organ Specificity; Parasympatholytics; Pirenzepine; Quinoxalines; Rats; Receptors, Muscarinic; Synapses | 1991 |
Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Atropine; Bungarotoxins; Cerebral Cortex; Dimethylphenylpiperazinium Iodide; Electric Stimulation; Evoked Potentials; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Male; Mecamylamine; Membrane Potentials; Muscarine; Neurons; Nicotine; Pirenzepine; Pyramidal Tracts; Quinoxalines; Rats; Rats, Sprague-Dawley; Scopolamine; Synaptic Transmission; Tubocurarine | 1993 |
Properties of carbachol-induced oscillatory activity in rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; Animals; Atropine; Bicuculline; Carbachol; Dicyclomine; Evoked Potentials; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; GABA-B Receptor Antagonists; Hippocampus; In Vitro Techniques; Kinetics; Male; Microelectrodes; Neurons; Nicotine; Oscillometry; Phosphinic Acids; Pirenzepine; Potassium; Propanolamines; Pyramidal Cells; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, AMPA; Receptors, GABA-B | 1997 |
Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Anguilla; Animals; Arginine; Atropine; Detergents; Enzyme Inhibitors; Female; Free Radical Scavengers; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Molsidomine; Muscarinic Antagonists; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Octoxynol; omega-N-Methylarginine; Ornithine; Oxadiazoles; Parasympatholytics; Pirenzepine; Quinoxalines; Superoxide Dismutase | 2001 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Bicuculline; Dose-Response Relationship, Drug; Duodenum; Elapid Venoms; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Muscarinic Agonists; Muscarinic Antagonists; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Oxadiazoles; Penicillamine; Pirenzepine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Suramin | 2006 |
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexylamines; Gene Expression Regulation; Guinea Pigs; Heart Atria; Humans; Male; Models, Molecular; Molecular Structure; Muscarinic Antagonists; Muscle, Skeletal; Pirenzepine; Protein Binding; Quinoxalines; Rabbits; Receptors, Muscarinic; Structure-Activity Relationship; Vas Deferens | 2008 |